501 related articles for article (PubMed ID: 1698526)
1. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
Arch Otorhinolaryngol; 1989; 246(5):373-7. PubMed ID: 2480104
[TBL] [Abstract][Full Text] [Related]
3. [Combined therapy of locally advanced squamous epithelial cancers in the area of the head and neck].
Fountzilas G; Daniilidis J; Kalogera-Fountzila A; Apostolidis T; Vritsios A; Tourkantonis A
Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):165-70. PubMed ID: 2455206
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study.
Fountzilas G; Kosmidis P; Sridhar KS; Kalogera-Fountzila A; Banis K; Dimitriadis A; Avramidis V; Nikolaou A; Zaramboukas T; Skarlos D; Vritsios A; Daniilidis I
Cancer Invest; 1996; 14(3):189-96. PubMed ID: 8630678
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM
Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
[TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer.
Zidan J; Kuten A; Rosenblatt E; Robinson E
Oral Oncol; 1997 Mar; 33(2):129-35. PubMed ID: 9231171
[TBL] [Abstract][Full Text] [Related]
9. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
10. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
Vokes EE; Mick R; Lester EP; Panje WR; Weichselbaum RR
J Clin Oncol; 1991 Aug; 9(8):1376-84. PubMed ID: 2072141
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
Bensmaine M el-A ; Guillot T; Bernal ET; Janot F; Sigal R; Domenge C; Wibault P; Armand JP; Cvitkovic E
Am J Clin Oncol; 1996 Aug; 19(4):356-62. PubMed ID: 8677904
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
Hussain M; Benedetti J; Smith RE; Rodriguez GI; Schuller D; Ensley J
Cancer; 1995 Oct; 76(7):1233-7. PubMed ID: 8630903
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease.
Recondo G; Cvitkovic E; Azli N; Tellez Bernal E; de Vathaire F; Wibault P; Richard JM; Marandas P; Benahmed M; Domenge C
Cancer; 1991 Nov; 68(10):2109-19. PubMed ID: 1717121
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
[TBL] [Abstract][Full Text] [Related]
19. Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin.
Osoba D; Band PR; Connors JM; Goldie JH; Knowling MA; Fetherstonhaugh EM
Semin Oncol; 1992 Apr; 19(2 Suppl 5):25-9; discussion 30-1. PubMed ID: 1384140
[TBL] [Abstract][Full Text] [Related]
20. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
